机译:在具有高水平HBV DNA,HBsAg和HBEAG的无症状慢性HBV载体中的CD56昏暗NK上降低了CD56昏暗NK的CD122
Department of Laboratory Medicine The First Affiliated Hospital Zhejiang University School of;
State Key Laboratory for Infectious Diseases Diagnosis and Treatment Department of Infectious;
State Key Laboratory for Infectious Diseases Diagnosis and Treatment Department of Infectious;
Program in Molecular &
Translational Medicine (PMTM) Huzhou University;
Department of Laboratory Medicine The First Affiliated Hospital Zhejiang University School of;
Department of Laboratory Medicine The First Affiliated Hospital Zhejiang University School of;
Department of Laboratory Medicine The First Affiliated Hospital Zhejiang University School of;
Chronic HBV carriers; CD122; CD56dimNK; IFN-α2;
机译:在具有高水平HBV DNA,HBsAg和HBEAG的无症状慢性HBV载体中的CD56昏暗NK上降低了CD56昏暗NK的CD122
机译:在HBeAg阳性的慢性乙型肝炎乙型肝炎患者中,HBV逆转录酶/表面蛋白重叠序列中氨基酸取代的较高检测率与较低的血清HBV DNA和HBsAg水平相关
机译:根据正在治疗的HBsAg,HBeAg和HBV DNA水平预测恩替卡韦疗法对HBeAg阳性慢性乙型肝炎患者的反应
机译:吉林地区HBEAG阴性患者HBV-DNA分析
机译:权力和污名:检查中国学生对慢性乙型肝炎病毒携带者的污名化反应。
机译:HBV表面启动子II序列中的自然突变会影响HBeAg阳性慢性乙型肝炎患者的转录活性HBsAg和HBV DNA水平
机译:HBV表面启动子II序列中的天然存在的突变影响HBeAg阳性慢性乙型肝炎患者的转录活性,HBsAg和HBV DNA水平